Cellular signalling pathways: New targets in leukaemia therapy

被引:22
|
作者
Ravandi, F
Talpaz, M
Kantarjian, H
Estrov, Z
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Leukaemia, Houston, TX 77030 USA
[3] Univ Illinois, Dept Hematol Oncol, Chicago, IL USA
关键词
cellular signalling pathways; leukaemia; therapy;
D O I
10.1046/j.1365-2141.2002.03236.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:57 / 77
页数:21
相关论文
共 50 条
  • [11] Current concepts on apoptotic signalling pathways:: new targets for anticancer strategies
    Ségal-Bendirdjian, E
    Hillion, J
    Belmokhtar, CA
    BULLETIN DU CANCER, 2003, 90 (01) : 9 - 17
  • [12] microRNA expression in acute myeloid leukaemia: New targets for therapy?
    Fletcher, Daniel
    Brown, Elliott
    Javadala, Julliah
    Uysal-Onganer, Pinar
    Guinn, Barbara-ann
    EJHAEM, 2022, 3 (03): : 596 - 608
  • [13] Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways
    Cherifi, Chahrazad
    Monteagudo, Silvia
    Lories, Rik J.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [14] Activation of cellular signalling pathways by hypotonicity
    Tilly, BC
    van der Wijk, T
    de Jonge, HR
    CELL VOLUME REGULATION: THE MOLECULAR MECHANISM AND VOLUME SENSING MACHINERY, 1998, 1160 : 59 - 66
  • [15] Intracellular signalling pathways: targets to reverse immunosenescence
    Fulop, T.
    Witkowski, J. M.
    Le Page, A.
    Fortin, C.
    Pawelec, G.
    Larbi, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 187 (01): : 35 - 43
  • [16] WNT signalling pathways as therapeutic targets in cancer
    Anastas, Jamie N.
    Moon, Randall T.
    NATURE REVIEWS CANCER, 2013, 13 (01) : 11 - 26
  • [17] WNT signalling pathways as therapeutic targets in cancer
    Jamie N. Anastas
    Randall T. Moon
    Nature Reviews Cancer, 2013, 13 : 11 - 26
  • [18] Editorial: Targeting cellular signalling pathways for disease therapy: the potential of cellular reprogramming and protein kinase inhibitors
    Marensi, Vanessa
    Oliveira, Pedro Fontes
    Zamoner, Ariane
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [19] Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
    Nolan, Aoife A.
    Aboud, Nourhan K.
    Kolch, Walter
    Matallanas, David
    GENES, 2021, 12 (04)
  • [20] Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
    Falkenburg, JHF
    Willemze, R
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (03) : 415 - 425